SUMMARY Sultamicillin is a covalent union of ampicillin and the P lactamase inhibitor, sulbactam 899 
Introduction
Sultamicillin is a covalent union of two antimicrobials, the semisynthetic penicillin, ampicillin, and the P lactamase inhibitor, sulbactam (CP-45,899). We conducted two studies to see if a single dose of this new drug would be effective in treating gonorrhoea due to (3 lactamase (penicillinase) producing strains of Neisseria gonorrhoeae (PPNG) and non-PPNG, and to see if it was an acceptable alternative to spectinomycin and the new cephalosporins in treating infection with PPNG strains.
Patients and methods
We studied all patients with uncomplicated gonorrhoea attending the department of genitourinary medicine at this hospital during the study periods 1 November 1982 to 5 January 1983 and 9 March to 1 June 1983 except those hypersensitive to penicillin, travellers unable to attend for follow up, patients in whom syphilis was suspected, women not using oral contraception or an intrauterine device (IUD), and patients who declined to take a new drug. Accepted for publication 28 May 1984 Presumptive diagnoses were made by microscopical identification of typical Gram negative intracellular diplococci in smears taken from the urethra and, when indicated, from the rectum of men, from the urethra and cervix of all women, and from the rectum of sexual contacts. Specimens from the same sites, and the pharynx when indicated, were also cultured on selective medium' for N gonorrhoeae; cases not confirmed by culture were excluded.
Minimum inhibitory concentrations (MICs) of ampicillin alone and ampicillin and sulbactam in a 1:1 ratio were measured for all but 20 of the isolates in the first trial and all except nine in the second. All organisms with MICs of ampicillin of 0 25 mg/l or more were assessed for production of P lactamase as already described. 2 All patients were observed while swallowing the appropriate number of 375 mg sultamicillin tablets and two 500 mg tablets of probenecid. They were then asked to return after 1, 7, and 14 days. At each visit they were examined, and smears for Gram staining and cultures were taken as above. Patients in whom culture positive gonorrhoea was found during the follow up period and who admitted to having had sexual intercourse were excluded. Results
In the first trial 168 patients with gonorrhoea were treated with 1 5 g sultamicillin and 1 g probenecid; ampicillin and ampicillin-sulbactam. Table V shows of many of our PPNG strains. 5 The prevalence in this in greater detail the in vitro sensitivities of all isolates series was lower than previously reported. tested.
In Britain oral ampicillin is probably the Of the 337 patients treated in the two trials, three antimicrobial most commonly used in treating complained of nausea, four of nausea and abdominal gonorrhoea,6 although dosage varies. In the United pain, 13 of diarrhoea, and two developed a rash. All States the recommended dose for uncomplicated of these side effects were transitory and mild, and gonorrhoea is ampicillin 3 -5 g plus probenecid 1 g by none precipitated admission to hospital. Ten patients mouth.7 This treatment is ineffective against PPNG treated with the lower dose and nine treated with the strains and would be poor first line treatment in higher dose complained of these symptoms.
South East Asia. For PPNG strains usual treatments In addition to patients treated in these trials, 11 are either spectinomycin, resistance to which has harbouring PPNG strains were treated with 2 25 g been reported,8 or a new cephalosporin such as sultamicillin plus 1 g probenecid, of whom 10 cefotaxime.5 Such medications are expensive and, as responded satisfactorily. The total number of most of them must be given intramuscularly, syringes patients infected with these strains treated with the and needles further increase the cost. Injections also higher dose of sultamicillin was 16, of whom 15 take more time for nurses to administer and are less responded satisfactorily.
well tolerated by patients.
Clearly a single dose oral treatment for gonorrhoea Discussion that would cover all strains would be more acceptable. Sultamicillin with probenecid may The emergence of total resistance to penicillin in N provide such an alternative. The findings with the gonorrhoeae due to P lactamase production now 1-5 g regimen were unsatisfactory. The results with poses a considerable problem over treatment. In the 2 25 g dosage resembled those with sultamicillin Britain the prevalence of PPNG strains in gonococcal 2 g plus probenecid I g reported by Atia et al, 9 and isolates is still only about 5% ,3 but in parts of South show sultamicillin to be well tolerated and effective East Asia it is nearly 5O%o. West Africa is the source against PPNG and non-PPNG strains. Among 
